Similar articles

• [Mycologic long-term monitoring of ambulatory and inpatient treated children with malignant diseases during and following continuous polychemotherapy].

  Blaschke-Hellmessen R, Rönisch P, Birke I. Blaschke-Hellmessen R, et al. Kinderarztl Prax. 1984 Oct;52(10):456-64. Kinderarztl Prax. 1984. PMID: 6513280 German. No abstract available.
• [Platelet concentrate transfusion during polychemotherapy of children with solid tumors].

  Koposov PV, KovalevI VI, Strykov VA, Kovalev LV, Loseva MS, Starostina AIu, Prostomolotov OA, Zakharov MV. Koposov PV, et al. Vopr Onkol. 2002;48(3):365-8. Vopr Onkol. 2002. PMID: 12455364 Russian. No abstract available.
• Early hospital discharge followed by outpatient management versus continued hospitalization of children with cancer, fever, and neutropenia at low risk for invasive bacterial infection.

  Santolaya ME, Alvarez AM, Avilés CL, Becker A, Cofré J, Cumsille MA, O'Ryan ML, Payá E, Salgado C, Silva P, Tordecilla J, Varas M, Villarroel M, Viviani T, Zubieta M. Santolaya ME, et al. J Clin Oncol. 2004 Sep 15;22(18):3784-9. doi: 10.1200/JCO.2004.01.078. J Clin Oncol. 2004. PMID: 15365075 Clinical Trial.
• Cancer chemotherapy in young children: challenges and solutions.

  Koren G, Schechter T. Koren G, et al. Pediatr Blood Cancer. 2007 Dec;49(7 Suppl):1091-2. doi: 10.1002/pbc.21349. Pediatr Blood Cancer. 2007. PMID: 17943958 Review.
• [Antimicrobial therapy of febrile neutropenia--current developments].

  Karthaus M, Cornely OA, Südhoff T, Meran J. Karthaus M, et al. Wien Med Wochenschr. 2001;151(3-4):66-72. Wien Med Wochenschr. 2001. PMID: 11789421 Review. German.